(Q36351792)

English

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

M A Cheever

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

D B Thompson

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

J P Klarnet

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

P D Greenberg

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 May 1986

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Experimental Medicine

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

163

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1100-1112

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1 2- lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1 ,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl T cells trigger autonomously antigen-primed Ly23 T cells to cell proliferation and cytolytic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

Genetic control of the immune response to Thy-1 antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

30 September 2017

Allogeneic tumor rejection induced by the intravenous injection of Lyt-2 cytolytic T lymphocyte clones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

29 June 2018

Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

29 June 2018

In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

29 June 2018

Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4 clones and Lyt-2 cytolytic clones which recognize a tumor-specific cell surface antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

29 June 2018

Characterization of interleukin 2 (IL-2)-dependent cytotoxic T-cell clones. V. Transfer of resistance to allografts and tumor grafts requires exogenous IL-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

22 September 2018

Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

22 September 2018

T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188098

22 September 2018

Models for syngeneic adoptive chemoimmunotherapy of murine leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of early and delayed antitumor effects following curative adoptive chemoimmunotherapy of established leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

H-2 restriction of adoptive immunotherapy of advanced tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal migration of T lymphocyte clones

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo localization of cloned IL-2-dependent T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on chemically induced rat tumors. II. Partial protection against syngeneic lethal tumors by cloned syngeneic cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of Lyt-1 and Lyt-2 T cell cloned lines: stimulation of proliferation, lymphokine production, and self-destruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vivo behavior of T cell clones: altered migration due to loss of the lymphocyte surface homing receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3084700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1084/JEM.163.5.1100

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36351792&oldid=1519246005"